Table II.
Splenic DCs(×106) | BMmyeloid cells(×106) | Spleen B cells(×106) |
Thymic T cells(×106) |
|
---|---|---|---|---|
Flt3+
CMPs (104) |
0.27 ± 0.04 | 0.26 ± 0.09 | 3.70 ± 0.50 | <0.1 |
Flt3−
CMPs (104) |
0.04 ± 0.01 | 0.12 ± 0.02 | <0.1 | <0.1 |
The Flt3+ and Flt3− fractions of CMPs were purified and i.v. transferred to lethally irradiated Ly5.1 recipient mice. For DC production by the precursors, splenic DCs were analyzed 2 wk after precursor transfer. For myeloid cell production, the BM cells were prepared 1 wk after precursor transfer from the femoral and tibial bones of the recipient mice and analyzed for donor-derived Mac-1+ and Gr-1+ cells. For B cell and T cell production, the recipient spleen and thymus were analyzed 2 wk after precursor transfer. The cell numbers presented are the mean ± standard error from three experiments. Each experimental group contained two to three recipient mice.